Amphotericin B liposomal
To view the entire topic, please log in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
- Aspergillosis (in patients refractory to or intolerant of amphotericin B deoxycholate)
- Candidiasis (in patients refractory to or intolerant of amphotericin B deoxycholate)
- Cryptococcosis (in patients refractory to or intolerant of amphotericin B deoxycholate)
- Empiric therapy for presumed fungal infection in patients with febrile neutropenia
- Visceral leishmaniasis
NON-FDA APPROVED USES
- Zygomycetes and other invasive molds
- Coccidioidomycosis
- Histoplasmosis
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
- Aspergillosis (in patients refractory to or intolerant of amphotericin B deoxycholate)
- Candidiasis (in patients refractory to or intolerant of amphotericin B deoxycholate)
- Cryptococcosis (in patients refractory to or intolerant of amphotericin B deoxycholate)
- Empiric therapy for presumed fungal infection in patients with febrile neutropenia
- Visceral leishmaniasis
NON-FDA APPROVED USES
- Zygomycetes and other invasive molds
- Coccidioidomycosis
- Histoplasmosis
There's more to see -- the rest of this entry is available only to subscribers.